USE OF SODIUM TETRAPHENYL BORON FOR FABRICATION OF POTENTIOMETRIC MEMBRANE SENSOR FOR THE ASSAY OF OLANZAPINE IN PHARMACEUTICALS AND HUMAN URINE

RAJENDRA PRASAD NAGARAJU

Abstract


Olanzapine (OLP), chemically known as 2-Methyl-10-(4-methyl-piperazin-1-yl)-4H-3-thia-4,9-diaza-benzo[f]azulene, is an atypical antipsychotic drug. It is used for the treatment of schizophrenia and bipolar disorder. A new simple and selective membrane based potentiometric sensor was developed for potentiometric determination of olanzapine. The membrane was constructed using an ion-pair of OLP and sodium tetraphenyl boron in dioctyl phthalate and PVC. The membrane provides good linear Nernstian response covering relatively wide concentration range of 4 × 10-6 - 1 × 10-2 M OLP over pH range of 2.6-7.8. The detection limit for the developed sensor was found as 2.02 × 10-6 M. The response time of developed sensor is <10 s for the range of determination. The sensor showed good selectivity for OLP in the presence of various cations, anions and other organic molecules. The membrane was successfully applied in direct potentiometric determination of OLP in tablets. The percentage recovery of OLP, ranged from 96.2 to 99.68% with a mean standard deviation <5% indicates the adoptability of sensor for the direct estimation of OLP in pharmaceuticals. The developed sensor was used to determine OLP in spiked human urine sample and the satisfactory results were obtained.

Full Text:

PDF

References


K. Basavaiah, N. Rajendraprasad and K.B. Vinay, “Microtitrimetric determination of drug content of pharmaceuticals containing olanzapine in non-aqueous medium”, Chemical Industry and Chemical Engineering (Quarterly), vol. 15, pp. 77-81, 2009.

S. Firdous, T. Aman and A. Nisa, “Determination of olanzapine by UV spectrophotometry and non-aqueous titration”. Journal of Chemical Society of Pakistan, vo.l 27, pp.163-167, 2005.

K. Basavaiah and A.M.A. Sameer, “Sensitive and selective methods for the determination of olanzapine in pharmaceuticals using n-bromosuccinimide and two dyes”, International Journal of ChemTech Research, vol. 2, pp.660-668, 2010.

A. Krebs, B. Starczewska, H. Puzanowsha-Tarasiewicz and J. Sledz, “Spectrophotometric determination of olanzapine with N-bromosuccinimide and cerium(IV)sulphate”, Analytical Sciences, vol. 22, pp. 829-833, 2006.

A. Jasinska and E. Nalewajko, “Batch and flow-injection methods for the spectrophotometric determination of olanzapine”, Analytica Chimica Acta, vol. 508, pp. 165-170, 2004.

N. Rajendraprasad, K. Basavaiah, K. Tharpa and K.B. Vinay, “Quantitative determination of olanzapine in tablets with visible spectrophotometry using cerium(IV)sulphate and based on redox and complexation reactions”, Eurasian Journal of Analytical Chemistry, vol. 4, pp. 193-203, 2009.

N. Rajendraprasad and K. Basavaiah, “Highly sensitive spectrophotometric determination od olanzapine using Cerium(IV) and iron(II) complexex of 1,10-phenanthroline and 2,2’-bipyridyl”, Journal of Analytical Chemistry, vol. 65, pp. 482-488, 2010.

K. Basavaiah, A.M.A. Sameer and, K.B. Vinay, “New extractive spectrophotometric methods for the determination of olanzapine in pharmaceutical formulatins using bromocresol green”, Jordan Journal of Chemistry, vol. 5, pp. 101-117, 2010.

N. Rajendraprasad and K. Basavaiah, “Determination of olanzapine by spectrophotometry using permanganate”, Brazilian Journal of Pharmaceutical Sciences, vol. 45, pp. 539-550, 2009.

K. Basavaiah, K. Tharpa, N. Rajendraprasad, S.G. Hiriyanna and K.B. Vinay, “Spectrophotometric Determination of Antipsychotic Drug Olanzapine in Pharmaceuticals”, Jordan Journal of Chemistry, vol. 4, pp. 65-76, 2009.

A.A. Mohamed, “Kinetic and maximum-absorbance spectrophotometric methods for the determination of olanzapine”, Monatshefte fur Chemie/Chemical Monthly, vol. 139, pp. 1005-1010, 2008.

M.A. Raggi, G. Casamenti, R. Mandrioli, G. Izzo and E. Kenndler, “Quantification of olanzapine in tablets by HPLC, CZE, derivative spectrometry and linear voltammetry”, Journal of Pharmaceutical and Biomedical Analysis, vol. 23, pp. 973-981, 2000.

R.B. Patel, M.R. Patel, K.K. Bhatt and B.G. Patel, “Development and validation of an HPTLC method for determination of olanzapine in formulations”, Journal of AOAC International, vol. 93, pp. 811-819, 2010.

C.R. Shah, B.N. Suhagia, N.J. Shah, D.R. Patel and N.M. Patel, “Stability-indicating simultaneous HPTLC method for olanzapine and fluoxetine in combined tablet dosage form”, Indian Journal of Pharmaceutical Sciences, vol. 70, pp. 251-255, 2008.

S. Patel and N.J. Patel, “Simultaneous RP-HPLC and HPTLC estimation of fluoxetine hydrochloride and olanzapine in tablet dosage forms”. Indian Journal of Pharmaceutical Sciences, vol. 71, pp. 477-480, 2009.

O.V. Olesen and K. Linnet, “Determination of olanzapine in serum by high-performance liquid chromatography using ultraviolet detection considering the easy oxidizability of the compound and the presence of other psychotropic drugs”, Journal of Chromatography B: Biomedical Science Applications, vol. 714, pp. 309-315, 1998.

H. Weigmann, S. Härtter, M. Sabine, K. Werner, K. Godehard, D. Gerd and H. Chrostoph, “Simultaneous determination of olanzapine, clozapine and demethylated metabolites in serum by on-line column-switching high-performance liquid chromatography”. Journal of Chromatography B, vol. 759, pp. 63-71, 2001.

O.V. Olesen, B. Poulsen and K. Linnet, “Fully automated online determination of olanzapine in serum for routine therapeutic drug”, Therapeutic Drug Monitoring, vol. 1, pp. 51-55, 2001.

D. Concetta, M. Gaetana, S. Vincenza and S. Edoardo, “Determination of olanzapine in human-plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection”, Therapeutic Drug Monitoring, vol. 28, pp. 388-393, 2006.

L.J. Dusci, L.P. Hackett, L.M. Fellows and K.F. Liett, “Determination of olanzapine in plasma by high-performance liquid chromatography using ultraviolet absorbance detection”, Journal of Chromatography B, vol. 773, pp. 191-197, 2002.

M.A. Raggi, G. Casamenti, R. Mandrioli and V. Volterra, “A sensitive high-performance liquid chromatographic method using electrochemical detection for the analysis of olanzapine and desmethylolanzapine in plasma of schizophrenic patients using a new solid-solid phase extraction procedure”, Journal of Chromatography B, vol. 750, pp. 137-146, 2001.

M.A. Raggi, G. Casamenti, R. Mandrioli, S. Fanali, D. De Ronchi and V. Volterra, “Determination of the novel antipsychotic drug olanzapine in human plasma using HPLC with amperometric detection”, Chromatographia, vol. 51, pp. 562-566, 2000.

M.A. Raggi, R. Mandrioli, C. Sabbioni, N. Ghedini, S. Fanali and V. Volterra, “Determination of olanzapine and desmethylolanzapine in the plasma of schizophrenic patients by means of an improved HPLC method with amperometric detection”, Chromatographia, vol. 54, pp. 203-207, 2001.

M.A. Saracino, A. Koukopoulos, G. Sani, M. Amore and M.A. Raggi, “Simultaneous high-performance liquid chromatographic determination of olanzapine and lamotrigine in plasma of bipolar patients”, Therapeutic Drug Monitoring, vol. 29, pp.773-780, 2007.

C.B. Eap, J.L. Veuthey, D. Guillarme, A. Kottelat, S. Rudaz and E. Choong, “Therapeutic drug monitoring of seven psychotropic drugs and four metabolites in human plasma by HPLC-MS”, Journal of Pharmaceutical and Biomedical Analysis, vol. 50, pp. 1000-1008, 2009.

M. Josefsson, M. Roman, E. Skogh and M.L. Dahl, “Liquid chromatography/tandem mass spectrometry method for determination of olanzapine and N-desmethylolanzapine in human serum and cerebrospinal fluid”, Journal of Pharmaceutical and Biomedical Analysis, vol. 53, pp. 576-582, 2010.

M.A. Saracino, O. Gandolfi, R.O. Dall’Olio, L. Albers, E. Kenndler and M.A. Raggi, “Determination of olanzapine in “rat brain using liquid chromatography with coulometric detection and a rapid solid-phase extraction procedure”, Journal of Chromatography A, vol. 1122, pp. 21-27, 2006.

S.C. Kasper, E.L. Mattiuz, S.P. Swanson, J.A. Chiu, J.T. Johnson and C.O. Garner, “Determination of olanzapine in human breast milk by high-performance liquid chromatography”, Journal of Chromatography B, vol. 726, pp. 203-209, 1999.

X. Xuejun and T. Zhonghua, “Determination of olanzapine and its tablets by HPLC”, Zhongguo Yiyao Gongye Zazhi, vol. 35, pp. 46-48, 2004.

A. Pathak, S.J. Rajput, “Development of stability-indicating hplc method for simultaneous determination of olanzapine and fluoxetine in combined dosage forms”, Journal of Chromatographic Sciences, vol. 47, pp. 605-611, 2009.

B.V. Reddy, K.V.N. Suresh Reddy, J. Sreeramulu and G.V. Kanumula, “Simultaneous determination of olanzapine and fluoxetine by HPLC”, Chromatographia, vol. 66, pp. 111-114, 2007.

C.R. Shah, N.J. Shah, B.N. Suagia and N.M. Patel, “Simultaneous assay of olanzapine and fluoxetine in tablets by column high-performance liquid chromatography and high-performance thin-layer chromatography”, Journal of AOAC International, vol. 90, pp. 1573-1578, 2007.

S.G. Hiriyanna, K. Basavaiah, P.S.K. Goud, V. Dayanidhi, K. Raju and H.N. Pati, “Identification and characterization of olanzapine degradation products under oxidative stress conditions”, Acta Chromatographica, vol. 20, pp. 81-93, 2008.

A. Ensafi and A. R. Allafchian. “Novel and selective potentiometric membrane sensor for amiloride determination in pharmaceutical compounds and urine”, Journal of Pharmaceutical and Biomedical Analysis, vol. 47(4-5), pp. 802-806, 2008.

G. S. Kanberoglu, F. Coldur, C. Topcu and O. Cubuk. “A Flow‐injection potentiometric system for selective and sensitive determinationof serum lithium level”, IEEE Sensors Journal, vol. 15(11), pp. 6199-6207, 2015.

H. AlRabiah, A. Al-Majed, M. Abounassif and G.A.E.Mostaf, “Two novel potentiometric sensors for determination of clonidine in some pharmaceutical formulation”, International Journal of Electrochemical Science, vol. 11, pp. 6761 – 6774, 2016.

M.R. Ganjali, S. Karimi, S.J. Shahtaheri and P. Norouzi, “Determination of clonidine by potentiometry using PVC membrane electrode”, International Journal of Electrochemical Science, vol. 8, pp. 1999-2008, 2013.

E.M. Del Valle, “Cyclodextrin and their uses a review”, Process Biochemistry. vol. 39, pp. 1033-1046, 2004.

A.R. Hedges. “Industrial applications of cyclodextrins”, Chemical Reviews, vol. 98, pp. 2035-2044, 1998.

R. Yang, K.a. Li, K. Wang, F. Zhao, N. Li and F. Liu, “Porphyrin assembly on β-cyclodextrin for selective sensing and detection of a zinc ion based on the dual emission fluorescence ratio”, Analytical Chemistry, vol. 75, pp. 612-621, 2003.

A.M. El-Kosasy, M. Nebsen, M.K.A. El-Rahman, M.Y. Salem and M.G. El-Bardicy, “Comparative study of 2-hydroxy propyl beta cyclodextrin and calixarene as ionophores in potentiometric ion-selective electrodes for neostigmine bromide”, Talanta, vol. 85, pp. 913-918, 2011.

M. Trojanowicz, “Enantioselective electrochemical sensors and biosensors: A mini-review”, Electrochemistry Communications, vol. 38, pp. 47-52, 2014.

S.R. Patil, M. Turmine, V. Peyre, G. Durand and B. Pucci, “Study of β-cyclodextrin/fluorinated trimethyl ammonium bromide surfactant inclusion complex by fluorinated surfactant ion selective electrode”, Talanta vol. 74, pp. 72-77 (2007).

A.M. El-Kosasy, “Determination of hydroxyurea in capsules and biological fluids by ion-selective potentiometry and fluorimetry”, Journal of AOAC International, vol. 86, pp. 15-21, 2003.

K.I. Ozoemena and R-I. Stefan, “Enantioselective potentiometric membrane electrodes based on alpha-, beta- and gamma-cyclodextrins as chiral selectors for the assay of L-proline”, Talanta, vol. 66, pp. 501-504, 2005.

IUPAC Analytical Chemistry Division, “Recommendation for Nomenclature of Ion Selective Electrode”, Pure and Applied Chemistry, vol. 66, pp. 2527-2536, 1994.

IUPAC Analytical Chemistry Division, “Potentiometric selectivity coefficients of ion selective electrodes”, Pure and Applied Chemistry, vol. 72, pp. 1851-2082, 2000.




DOI: http://dx.doi.org/10.24294/ace.v2i2.179

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License

This site is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.